A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and efficacy for 52-week dosing of
JR-131 in renal anemia patients with chronic kidney disease (CKD).